IGHE and allergic disease: Given these results, authors proposed that Api m 11.0101 and Api m 11.0201 are minor HBV isoallergens with IgE-sensitizing potential that could be contributing to improve the efficacy of CRD of HBV allergy by helping to identify the subsets of patients sensitized to these proteins.